Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma.
Kropff MH, Lang N, Bisping G, Dominé N, Innig G, Hentrich M, Mitterer M, Südhoff T, Fenk R, Straka C, Heinecke A, Koch OM, Ostermann H, Berdel WE, Kienast J.
Kropff MH, et al. Among authors: mitterer m.
Br J Haematol. 2003 Aug;122(4):607-16. doi: 10.1046/j.1365-2141.2003.04473.x.
Br J Haematol. 2003.
PMID: 12899716
Free article.
Clinical Trial.